Cargando…

RNA Sequencing Reveals Upregulation of RUNX1-RUNX1T1 Gene Signatures in Clear Cell Renal Cell Carcinoma

In the past few years, therapies targeted at the von Hippel-Lindau (VHL) and hypoxia-inducible factor (HIF) pathways, such as sunitinib and sorafenib, have been developed to treat clear cell renal cell carcinoma (ccRCC). However, the majority of patients will eventually show resistance to antiangiog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Zuquan, Yu, Hongjie, Ding, Yan, Feng, Chenchen, Wei, Hanming, Tao, Sha, Huang, Dan, Zheng, Siqun Lilly, Sun, Jielin, Xu, Jianfeng, Fang, Zujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982423/ https://www.ncbi.nlm.nih.gov/pubmed/24783204 http://dx.doi.org/10.1155/2014/450621

Ejemplares similares

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
por: Liu, Shan, et al.
Publicado: (2021)

RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner
por: Abdallah, Mohamed Gaber, et al.
Publicado: (2021)

Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
por: Liu, Shan, et al.
Publicado: (2022)

The RUNX1/RUNX1T1 network: translating insights into therapeutic options
por: Swart, Laura E., et al.
Publicado: (2021)

Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1
por: Hagiwara, Shinya, et al.
Publicado: (2021)

Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1–RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1–RUNX1T1
por: Cho, Byung-Sik, et al.
Publicado: (2021)

RUNX1T1 function in cell fate
por: Hu, Nan, et al.
Publicado: (2022)

Pseudo-Chediak-Higashi granules in myeloid cells in therapy-related AML with RUNX1-RUNX1T1
por: Cho, Sung Ran, et al.
Publicado: (2018)

Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial–mesenchymal transition in clear-cell renal cell carcinoma
por: Yang, Ruo-Nan, et al.
Publicado: (2022)

Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia
por: Klco, Jeffery, et al.
Publicado: (2023)

RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia
por: Grinev, Vasily V., et al.
Publicado: (2021)

Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells
por: Omatsu, Yoshiki, et al.
Publicado: (2022)

RUNX1 and breast cancer
por: Mercado-Matos, Jose, et al.
Publicado: (2017)

Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement
por: Tokunaga, Kenji, et al.
Publicado: (2017)

Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019)

Hemophagocytic Lymphohistiocytosis in RUNX1::RUNX1T1 Positive AML with Blast Count Below 20%
por: Huang, Xingqin, et al.
Publicado: (2023)

Thrombospondin-1 Is a Putative Target Gene of Runx2 and Runx3
por: Shi, Xiuming, et al.
Publicado: (2013)

Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
por: Hornung, Roman, et al.
Publicado: (2018)

Unique N-terminal sequences in two Runx1 isoforms are dispensable for Runx1 function
por: Nieke, Sebastian, et al.
Publicado: (2017)

Runx1 protects against the pathological progression of osteoarthritis
por: Zhou, Chenchen, et al.
Publicado: (2021)

ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells
por: Redondo Monte, Enric, et al.
Publicado: (2020)

RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks
por: Kellaway, Sophie G., et al.
Publicado: (2020)

Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
por: Shaikh, Anam Fatima, et al.
Publicado: (2020)

Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1::RUNX1T1
por: Hwang, Sang Mee, et al.
Publicado: (2022)

Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes
por: Ogawa, Eisaku, et al.
Publicado: (2022)

Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3(+) inducible regulatory T cells
por: Klunker, Sven, et al.
Publicado: (2009)

Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells
por: Li, Lequn, et al.
Publicado: (2012)

RUNX‐mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins
por: Anderson, Gail, et al.
Publicado: (2017)

Runx1 is upregulated by STAT3 and promotes proliferation of neonatal rat cardiomyocytes
por: Suzuki, Shota, et al.
Publicado: (2023)

The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
por: Homan, Claire C., et al.
Publicado: (2021)

Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations
por: Höllein, Alexander, et al.
Publicado: (2019)

RUNX1 as a recombinase cofactor
por: Cieslak, Agata, et al.
Publicado: (2015)

RUNX1 Dosage in Development and Cancer
por: Lie-a-ling, Michael, et al.
Publicado: (2020)

Co-existence of RUNX1-RUNX1T1 and BCR-ABL1 in acute myeloid leukemia: a case report
por: Park, Suji, et al.
Publicado: (2023)

MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO
por: Kohrs, Nicole, et al.
Publicado: (2016)

Etoposide-induced DNA damage in a chromosomal breakpoint of RUNX1 gene is independent of RUNX1 expression
por: Schnake, Nicolás, et al.
Publicado: (2019)

A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma
por: Wu, Chen-Yan, et al.
Publicado: (2021)

RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma
por: Song, Xiandong, et al.
Publicado: (2022)

RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
por: Loke, Justin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1p7k3258vorcgpdl1vkr147p06